You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study optimized a three-drug chemotherapy protocol for advanced Ehrlich-Ascites-Tumor (EAT) by synchronizing cells with hydroxyurea (HU) and vincristine (VCR) before Adriamycin (ADM) treatment, significantly improving survival rates.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: